Latest news Think It’s Too Late to Buy This Leading Biotech Stock? Here’s Why There’s Still Time. @themotleyfool #stocks $VKTXSeptember 7, 2025 The market may have been too quick to dismiss this biotech’s pipeline prospects after a recent trial result.
